ACIP Unveils Its 2024 Adult Immunization Recommendations — Schedule must be more user-friendly to improve vaccine uptake, critics say by Katherine Kahn , Staff Writer, MedPage Today January 11, 2024 ...

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a notable shift in vaccine guidance ...

In an update to recommendations from June, in three unanimous votes, ACIP recommended a second dose of the 2024-2025 COVID vaccine for adults ages 65 and older, as well as people ages 6 months to ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

While ACIP's recommendation of a vaccine has typically been a requirement for payor coverage, Berger said that it is likely other health organizations will need to come out with their own guidelines.

The Advisory Committee on Immunization Practices has issued an update to their interim recommendations regarding the use of mRNA vaccines authorized for the prevention of COVID-19.

The CDC’s Advisory Committee on Immunization Practices (ACIP) members expressed their support for these COVID-19 changes and the associated implications and implementation. These changes include: ...

ACIP consists of 15 experts who are voting members primarily responsible for the vaccine recommendations. The secretary of the U.S. Department of Health and Human Services selects the committee ...

The US Centers for Disease Control and Prevention updated its recommendations for the Pfizer/BioNTech Covid-19 vaccine booster on Wednesday to include children as young as 12, at least five months ...

Vaccine advisers to the US Centers for Disease Control and Prevention will meet Thursday to make recommendations on how to address new safety issues concerning the Johnson & Johnson Covid-19 ...

The Advisory Committee on Immunization Practices, or ACIP, recommended that Covid-19 booster shots be offered to adults 65 and older as well as to individuals 50-64 with underlying health conditions.

In an update to recommendations from June, in three unanimous votes, ACIP recommended a second dose of the 2024-2025 COVID vaccine for adults ages 65 and older, as well as people ages 6 months to ...